TP53 and metastatic malignant neoplasm in the lymph nodes: TP53 mutations were positively associated with visceral metastases (χ2Q = .046), soft tissue and lymph node metastases (χ2Q = .042), and a number of disease sites (Cochran-Armitage Q = .009).